Ziqiang Zhao

Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA‐HF study)

M. Burch, C. Canter, R. Shaddy, 2017, American heart journal.

The Prognostic Role of Peripheral Lymphocyte Subsets in Patients With Acute Pancreatitis

Jie Shen, Jiaqing Shen, Ziqiang Zhao, 2019, The American journal of the medical sciences.

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.

Sanjiv J. Shah, R. Wachter, A. Baldridge, 2021, JAMA.

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial

Sanjiv J. Shah, R. Wachter, M. Cowie, 2020, ESC heart failure.

Baseline characteristics of patients in the PARALLAX trial: insights into quality of life and exercise capacity in heart failure with preserved ejection fraction

Sanjiv J. Shah, R. Wachter, M. Cowie, 2021, European journal of heart failure.

Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction

S. Solomon, J. McMurray, F. Zannad, 2021, Journal of the American Heart Association.